Products, activities and outcomes
with immutable genealogy
Data and insights securely on a
trusted, need-to-know basis
FDA Approves Rymedi Pilot Tracking Specialty Medicines Across Health Systems
The FDA approved Rymedi’s pilot testing implementation of the Drug Supply Chain Security Act for specialty medicines across health systems with partners Indiana University Health, WakeMed Hospitals and Health, Temptime/Zebra, Good Shepherd Pharmacy/Remedichain, the Center for Supply Chain Studies and the Global Health Policy Institute.
With technology designed for the highest global regulations, we help you capture, track and share your data for smarter, faster health impact
Real-World Evidence (RWE) is transforming health innovation. By monitoring the use and outcomes of in-market medicines and devices, product development is accelerating and healthcare providers are improving care. Rymedi helps RWE deliver greater value with enhanced data integrity and more options for data sharing.
Accelerate regulatory approvals
Offer companion analytics for diagnostics and treatments
Provide smart safety and efficacy assurance
Expand data monetization options
Manufacturing for Pharmaceuticals & Medical Devices
Life sciences manufacturing is getting smarter and leaner. While traceability requirements increase worldwide, manufacturers are leveraging improved quality management for competitive advantage with customers and regulators. Data also provides the key to targeted process improvements and liability reduction. Keep all your existing systems and use Rymedi to enrich your data and improve overall value.
Assure customers and regulators full cGXP traceability
Reduce liabilities with compliance automation and targeted remediation
Enhance performance with data-driven costing, training and IRs
Maintain versioning to reduce the cost of your IQ/OQ/PQ processes
Data is driving supply chain efficiencies and risk reduction. New supply traceability regulations are guarding against counterfeits and securing medicine and device quality across distribution networks. Trusted product traceability also enables business model innovations for expanded market access. Let Rymedi turn your supply intelligence into smart value chains.
Provide higher quality assurance
Streamline logistics management
Link compliance data with other data for higher value
Expand differential pricing and contracting options across varied markets
With collaboration accelerating breakthroughs, Collaborative Research Notebook (CRN) is Rymedi’s solution to research management. The blockchain-enabled dashboard, IoT integration, and collaboration tools link to immutable records of activities relevant to publication credits and intellectual property claims. Data access on a permissioned need-to-know basis provides targeted data sharing, while holding back elements crucial for trade secrecy. Rymedi allows researchers to focus on their objectives and fully harness collaborative science, rather than worry about trademarks or security.
Eliminate intellectual property disputes
Automate regulatory compliance
Enhance verification of cleaned and calibrated equipment
Enable secure data sharing between parties
Clinical Trials Management
Clinical trials are being revolutionized by digital technologies. Digital data from wearables, mHealth apps, devices and EMRs requires regulatory-compliant data plumbing for full reliance by regulators. Meanwhile, labor-intensive transcription, monitoring and auditing processes account for much of the cost of later-stage trials. Rymedi data infrastructure is paving the highway towards faster, leaner, smarter trial design and management.
Automate data capture, monitoring and auditing
Harness real-time data visibility and analytics across sites and partners
Accelerate validated investigator payments
Leverage permissioned, targeted data sharing for research alliances
With the signing into law of the latest U.S. Farm Bill, CBD products are coming under federal regulation. Greater regulatory clarity is already driving an explosion of interstate and global CBD market growth. Rymedi is providing pharmaceutical-grade compliance and quality assurance for a trusted, thriving global CBD market.
Accelerate market access and growth
Validate hemp producers through pharma regulatory compliance
Track and trace from seed to finished products
Provide quality risk management throughout product life-cycles
Mongolia Hepatitis C Elimination Case Study
Rymedi is proud to contribute to Mongolia’s progress as the first country to eliminate Hepatitis C
Making Connected Health Technology Easy
Our platform integrates with your existing technology, allowing your organization to unlock the power of your data